Taiho Oncology, Inc.
Taiho - Model TAS6417 -Tyrosine Kinase Inhibitor
Tyrosine Kinase Inhibitor of EGFR exon 20 insertion mutations. Non-Small Cell Lung Cancer (Phase 1/2) PHASE 2.
Most popular related searches
Tyrosine Kinase Inhibitor of EGFR exon 20 insertion mutations. Non-Small Cell Lung Cancer (Phase 1/2) PHASE 2.